OUTCOME OF LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN UNDER THE AGE OF 24 MONTHS- LCH-III PROTOCOL

被引：0
|
作者：
Moschovi, M. [1 ]
Nikolaou, M. [1 ]
Zampogiannis, A. [1 ]
Tourkantoni, N. [1 ]
Nikas, J. [2 ]
Hadjigeorgi, C. [2 ]
机构：
[1] Univ Athens, Dept Pediat 1, Hematol Oncol Unit, Athens, Greece
[2] Aghia Sofia Childrens Hosp, Dept Radiol, Athens, Greece
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1391
引用
收藏
页码：558 / 558
页数：1
相关论文
共 50 条
  • [1] CLINICAL PRESENTATION AND OUTCOME IN CHILDREN WITH LCH UNDER THE AGE OF 24 MONTHS
    Moschovi, Maria
    Zampogiannis, Archontis
    Adamaki, Maria
    Tourkantoni, Natalia
    Nikas, John
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : S12 - S12
  • [2] Clinical Presentation, Management and Outcome of Langerhans Cell Histiocytosis (LCH) in Children
    Petrikkos, Loizos
    Papadakis, Vassilios
    Tzotzola, Vasiliki-Sotiria
    Antoniadi, Kondilia
    Dendrinos, Vassilios
    Rigatou, Efthymia
    Stefanaki, Kalliopi
    Polychronopoulou, Sophia
    [J]. PEDIATRIC BLOOD & CANCER, 2016, 63 : S29 - S29
  • [3] Langerhans Cell Histiocytosis (LCH) in Egyptian Children: Does Reactivation Affect the Outcome?
    Sedky, Mohamed Mahmoud Sedky
    Rahman, Hany Abdel
    Moussa, Emad
    Taha, Hala
    Raafat, Tarek
    Hassanein, Omayma
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2016, 83 (03): : 214 - 219
  • [4] OUTCOME OF LANGERHANS CELL HISTIOCYTOSIS (LCH) - A SIXTEEN YEARS STUDY
    Raza, Muhammad Rafie
    Maqsood, Sidra
    Zia, Nida
    Ashraf, Shamvil
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S25 - S25
  • [5] EVENT FREE SURVIVAL OF PATIENTS WITH MULTISYSTEM-RISK LANGERHANS CELL HISTIOCYTOSIS IS SUBOPTIMAL WITH LCH-III PROTOCOL: 8-YEARS CHANDIGARH, INDIA EXPERIENCE
    Totadri, S.
    Bansal, D.
    Trehan, A.
    Srinivasan, R.
    Varma, N.
    Kakkar, N.
    Saxena, A. K.
    Bhatia, P.
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : S222 - S222
  • [6] LANGERHANS CELL HISTIOCYTOSIS (LCH) IN CHILDREN: A SINGLE INSTITUTION EXPERIENCE
    Papageorgiou, T.
    Pana, Z. D.
    Tsotoulidou, V.
    Tragiannidis, A.
    Hatzipantelis, E.
    Athanasiadou, P. F.
    [J]. ACTA PAEDIATRICA, 2010, 99 : 81 - 81
  • [7] LONG-TERM OUTCOME IN CHILDHOOD LANGERHANS CELL HISTIOCYTOSIS (LCH)
    Schlederer, Stefan
    Madunic, Andrea
    Thiem, Elfriede
    Calaminus, Gabriele
    Haimann, Ina
    Kaatsch, Peter
    Lehrnbecher, Thomas
    Potschger, Ulrike
    Minkov, Milen
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S28 - S28
  • [8] High Risk Langerhans Cell Histiocytosis (LCH) in Egyptian Children: The Role of Salvage in Improving the Outcome
    Sedky, M. S.
    Hamoda, A.
    Taha, H.
    Iman, Z.
    Hassanain, O.
    Elhaddad, A.
    [J]. PEDIATRIC BLOOD & CANCER, 2018, 65 : S402 - S402
  • [9] Langerhans Cell Histiocytosis (LCH) in Children: Clinical Presentation, Management and Outcome of a Clonal Myeloid Neoplasia
    Petrikkos, L.
    Papadakis, V.
    Tzotzola, V. S.
    Antoniadi, K.
    Dendrinos, V.
    Stefanaki, K.
    Polychronopoulou, S.
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 : S359 - S359
  • [10] THE IMPACT OF GASTRO-INTESTINAL INVOLVEMENT AT DIAGNOSIS ON OVERALL SURVIVAL IN PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS (LCH) - A RETROSPECTIVE ANALYSIS OF DAL-HX, LCH-I, LCH-II, AND LCH-III
    Potschger, Ulrike
    Thiem, Elfriede
    Arico, Maurizio
    Astigarraga, Itziar
    Braier, Jorge
    Donadieu, Jean
    Grois, Nicole
    Gadner, Helmut
    Henter, Jan-Inge
    Janka-Schaub, G.
    McClain, Ken
    Weitzman, Sheila
    Windebank, Kevin
    Minkov, Milen
    van den Bos, Cor
    Abla, Oussama
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S25 - S25
12345